Related Experiment Video
Updated: Jul 12, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Thailand: government issues compulsory licences for HIV/AIDS drugs
Insights
Thailand issued compulsory licenses for heart disease and HIV/AIDS drugs, including Plavix and Kaletra, to reduce medication costs. This action followed a prior compulsory license for the HIV/AIDS drug Efavirenz.
Area of Science:
- Pharmaceutical policy
- Global health
- Intellectual property rights
Background:
- Thailand's government implemented compulsory licensing for key medications in late 2006 and early 2007.
- The objective was to decrease the cost of essential drugs for treating heart disease and HIV/AIDS.
Discussion:
- Compulsory licensing allows governments to override patent rights in specific circumstances, such as public health crises.
- This policy tool can enhance access to affordable medicines.
Key Insights:
- Plavix (heart disease) and Kaletra (HIV/AIDS) were targeted in January 2007.
- Efavirenz, an HIV/AIDS medication, was previously subjected to compulsory licensing in November 2006.
Outlook:
- These measures highlight Thailand's proactive approach to pharmaceutical access.
- Further analysis may explore the long-term impact on drug pricing and availability.
Abstract:
In January 2007, the government of Thailand issued compulsory licences for two medicines in an effort to lower prices on drugs for treatment of heart disease and HIV/AIDS. The drugs in question are Plavix, a blood thinner for heart disease, and the HIV/AIDS drug Kaletra. A compulsory licence had previously been issued for Efavirenz, another HIV/AIDS drug, in November 2006.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Drug Regulation
Sexually Transmitted Infections
Antiviral Nucleoside Inhibitors
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Control Governance: Regulatory Bodies and Their Impact

